 This research study is being conducted to compare the safety and effectiveness of the investigational medication, LdT telbivudine versus adefovir dipivoxil, a drug approved by the Food and Drug Administration FDA for the treatment of hepatitis B infection. The results for patients taking LdT will be compared to results for patients taking adefovir dipivoxil. 